Genzyme (GENZ) Withdraws Bioenvision's European Filing of Evoltra in Elderly AML Patients
Tweet Send to a Friend
Genzyme Corp. (Nasdaq: GENZ) announced the withdrawal of the European application to extend the Evoltra product label to include ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


